Hemovigilance encompasses surveillance throughout the blood transfusion process — from blood collection to recipient follow-up — in order to identify and prevent adverse effects associated with transfusing blood products. This brief highlights challenges with developing comprehensive hemovigilance systems in low- and middle-income countries, shares best practices and innovations, and provides recommendations.
Developed in partnership with the R4D-led USAID Health Systems Strengthening Accelerator and Health Strategy and Delivery Foundation.
